Skip to content
1 Minute Read

Clinical Research IO’s Survey Finds That Coronavirus is Disrupting Clinical Research Sites

Clinical Research IO‘s recent web survey found that COVID-19 is disrupting clinical research sites worldwide. The results are indicative of a significant slowdown in new drug development and long term effects on healthcare in general.

  • 25% of sites have stopped recruiting
  • Of the 75% that are continuing enrollment, about half (37%) are considering halting new patient enrollment
  • Sites that are still enrolling report on average, a 27% drop in recruitment

This means that aggregate recruiting is down by approximately 50% and studies will need double the time to fill enrollment. If half of the 75% stop recruiting, then clinical trial enrollment timelines will increase by four times.

Among the sites that are still conducting study visits, challenges remain.

  • Patient retention has started to fall, with an average decline of 9%,
  • The number of protocol deviations have risen, with an average increase of 4%
  • Nearly two thirds of sites (63%) have prohibited on site monitoring visits, thus inhibiting effective oversight by sponsors
  • These values are expected to increase with ongoing travel limitations and quarantines

In addition to identifying declining enrollment and retention rates, the survey revealed that over 90% of sites would utilize sponsor provided technology, meaning a direct electronic data capture tool combined with a document upload feature.

The web survey was fielded from March 19-23, 2020. A total of 73 sites across different therapeutic focuses participated.

by Maxine Lai Customer Success Manager at CRIO
Share this post
You may also find interesting
Explore our Blog
21 cfr compliance update
Running a Site
5 Minute Read -

21 CFR Part 11 Regulation Compliance Update

Compliance Update:  The 21 CFR Part 11 Regulation is a cornerstone of conducting clinical trials in today’s world.  The release of the regulation 1997 established guidelines for the use of electronic records and electronic signatures in FDA-regulated industries and had a significant impact on the pharmaceutical and medical device industries. The FDA began working on...

The Current State of Clinical Trials in Ukraine—A Conversation with Dr. Roman Fishchuk
Running a Site
4 Minute Read -

The Current State of Clinical Trials in Ukraine—A Conversation with Dr. Roman Fishchuk

Meet Dr. Roman Fishchuk, an esteemed otorhinolaryngologist (ENT) whose journey in the healthcare field has been marked by a commitment to providing medical care and innovative treatment options through clinical trials in his native Ukraine. Having graduated from Ivano-Frankivsk National Medical University, Dr. Fishchuk specialized in otolaryngology and completed a Master’s degree at the University...

Geting Ready for Data Migration with CRIO
Running a Site
3 Minute Read -

Transitioning to CRIO? How to Get Your Data Ready for Migration

You have just signed on to use CRIO and you are excited to get started. Even if you are moving primarily from paper, you may have data that you want to migrate into CRIO rather than having to re-enter it. For many of our new clients, they have a wealth of information available in spreadsheets...

Get articles delivered to your inbox, every week